VWWMG
DNA icon

Vermillion & White Wealth Management Group’s Ginkgo Bioworks DNA Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$41 – 391
2024
Q3 		$41 Hold
5
– – ﹤0.01% 347
2024
Q2 		$67 Hold
5
– – ﹤0.01% 370
2024
Q1 		$232 Buy
+5
New +$259 ﹤0.01% 336

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Vermillion & White Wealth Management Group's DNA Position: Q4 2024 in Review

Vermillion & White Wealth Management Group sold out of Ginkgo Bioworks (DNA) in Q4 2024, closing a stake of 5 shares — an estimated $41 sold.

Vermillion & White Wealth Management Group first reported a position in DNA in Q1 2024 and held it in 3 quarters. The position peaked at $232 in Q1 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q4 2024.

  • Vermillion & White Wealth Management Group reported no remaining Ginkgo Bioworks position as of Q4 2024 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 5 Ginkgo Bioworks shares in Q4 2024, an estimated $41.
  • Vermillion & White Wealth Management Group first reported a position in Ginkgo Bioworks in Q1 2024 and held it in 3 quarters.
  • Vermillion & White Wealth Management Group's Ginkgo Bioworks position peaked at $232 in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2024.

Based on Vermillion & White Wealth Management Group's 13F filing for Q4 2024, filed 14 Feb 2025.